Keio Innovation Initiative
Stage agnostic tech and life sciences focused venture capital firm investing primarily in Japan
About This Fund
Keio Innovation Initiative is a satge agnostic venture capital firm. Makes investments in territories such as Japan. Invests in tech and life sciences companies that are operating in sectors like Biopharma, HealthTech and SportsTech. Notable investments include Kringle Pharma, CureApp, BONX.
Investment Focus
What They Look For
Academia-originated deep tech startups, primarily commercializing Keio University research (expanded to other universities/research institutes), Japan-focused, leveraging innovative technology/scientific knowledge for large societal impact (healthcare, productivity, environment), high difficulty projects
Preparing to pitch Keio Innovation Initiative?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →